RadNet/$RDNT
1D1W1MYTD1Y5YMAX
Capital at risk
About RadNet
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
- Ticker
- $RDNT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 9,060
- Headquarters
- Los Angeles, United States
- Website
- www.radnet.com
RadNet Metrics
BasicAdvanced
$5.9B
-
-$0.27
1.38
-
Price and volume
Market cap
$5.9B
Beta
1.38
52-week high
$85.84
52-week low
$50.82
Average daily volume
733K
Financial strength
Current ratio
1.484
Quick ratio
1.39
Long term debt to equity
1.494
Total debt to equity
1.567
Interest coverage (TTM)
1.45%
Profitability
EBITDA (TTM)
279.119
Gross margin (TTM)
17.28%
Net profit margin (TTM)
-0.93%
Operating margin (TTM)
4.76%
Effective tax rate (TTM)
44.90%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
1.74%
Return on equity (TTM)
1.50%
Valuation
Price to revenue (TTM)
2.557
Price to book
5.42
Price to tangible book (TTM)
-21.85
Price to free cash flow (TTM)
80.179
Free cash flow yield (TTM)
1.25%
Free cash flow per share (TTM)
0.942
Growth
Revenue change (TTM)
18.92%
Earnings per share change (TTM)
36.13%
3-year revenue growth (CAGR)
14.08%
10-year revenue growth (CAGR)
10.20%
3-year earnings per share growth (CAGR)
7.32%
10-year earnings per share growth (CAGR)
1.35%
What the Analysts think about RadNet
Analyst ratings (Buy, Hold, Sell) for RadNet stock.
Analyst projections of the future price of RadNet stock.
Bulls say / Bears say
RadNet’s Digital Health segment revenue grew 56.5% year-over-year to $32.4 million in Q2 2026, and Annual Recurring Revenue nearly doubled to $105.5 million, underscoring the segment’s rapid SaaS-like expansion. (Reuters)
Aggregate advanced imaging procedural volumes rose 19.7% in Q1 2026, driven by strong demand for MRI, CT and PET/CT, boosting revenue and margins in higher-value services. (Reuters)
After its Q2 2026 beat, RadNet raised full-year 2026 Imaging Center guidance to $2.37–$2.42 billion in revenue, $345–$358 million in Adjusted EBITDA, and $115–$125 million in free cash flow, reflecting management’s confidence in core operational momentum. (Reuters)
RadNet’s Q2 2026 net income fell 48% year-over-year to $7.5 million, exposing earnings volatility amid rising operating and investment costs. (Reuters)
Following Q1 2026 results, RadNet’s stock traded at approximately 77 times forward earnings, well above the industry average, suggesting valuation may be stretched if growth moderates. (Reuters)
Despite 51.5% revenue growth to $29.1 million in Q1 2026, the Digital Health segment’s adjusted EBITDA fell to $1.3 million, indicating profitability pressure from rapid scaling investments. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2026.
RadNet Financial Performance
Revenues and expenses
RadNet Earnings Performance
Company profitability
Upcoming events
No upcoming events
RadNet News
AllArticlesVideos
Funds containing RadNet
AllEURUSDGBP
Fund name | Fund size | $RDNT weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.40% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.25% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.25% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.18% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.